OP Asset Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-52,385
Closed -$987K 809
2025
Q4
$987K Buy
52,385
+27,144
+108% +$455K 0.01% 593
2025
Q3
$367K Buy
25,241
+2,707
+12% +$38.6K ﹤0.01% 701
2025
Q2
$440K Buy
22,534
+19,528
+650% +$347K 0.01% 686
2025
Q1
$53.4K Buy
+3,006
New +$64.7K ﹤0.01% 794

Other funds holding CDNA

OP Asset Management's CDNA Position: Q1 2026 in Review

OP Asset Management sold out of CareDx (CDNA) in Q1 2026, closing a stake of 52,385 shares — an estimated $987K sold.

OP Asset Management first reported a position in CDNA in Q1 2025 and held it in 4 quarters. The position peaked at $987K in Q4 2025. 190 funds tracked by Wall St. Rank hold CDNA as of Q1 2026.

  • OP Asset Management reported no remaining CareDx position as of Q1 2026 after selling out during the quarter.
  • OP Asset Management sold 52,385 CareDx shares in Q1 2026, an estimated $987K.
  • OP Asset Management first reported a position in CareDx in Q1 2025 and held it in 4 quarters.
  • OP Asset Management's CareDx position peaked at $987K in Q4 2025.
  • 190 funds tracked by Wall St. Rank held CareDx as of Q1 2026.

Based on OP Asset Management's 13F filing for Q1 2026, filed 9 Apr 2026.